241 related articles for article (PubMed ID: 11212730)
1. [Adenosine deaminase deficiency].
Sakiyama Y
Ryoikibetsu Shokogun Shirizu; 2000; (32):32-4. PubMed ID: 11212730
[No Abstract] [Full Text] [Related]
2. [Adenosine deaminase deficiency].
Okawa H
Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):240-2. PubMed ID: 9833480
[No Abstract] [Full Text] [Related]
3. Cost analysis of treatments for severe combined immunodeficiency patients caused by adenosine deaminase deficiency: comparison of gene therapy and bone marrow transplantation.
Imai H
Hokkaido Igaku Zasshi; 1998 Mar; 73(2):137-45. PubMed ID: 9612707
[TBL] [Abstract][Full Text] [Related]
4. Treatment of patients with severe combined immunodeficiency due to adenosine deaminase (ADA) deficiency by autologous transplantation of genetically modified bone marrow cells.
Hoogerbrugge PM; Vossen JM; v Beusechem VW; Valerio D
Hum Gene Ther; 1992 Oct; 3(5):553-8. PubMed ID: 1420454
[No Abstract] [Full Text] [Related]
5. [It is no more about cancer, but it is already about gene therapy].
Jeanteur P
Bull Cancer; 2000 Jun; 87(6):445-6. PubMed ID: 10928794
[No Abstract] [Full Text] [Related]
6. Drug evaluation: ADA-transduced hematopoietic stem cell therapy for ADA-SCID.
Taupin P
IDrugs; 2006 Jun; 9(6):423-30. PubMed ID: 16752313
[TBL] [Abstract][Full Text] [Related]
7. Adenosine deaminase deficiency: clinical expression, molecular basis, and therapy.
Hershfield MS
Semin Hematol; 1998 Oct; 35(4):291-8. PubMed ID: 9801258
[TBL] [Abstract][Full Text] [Related]
8. [Adenosine deaminase (ADA) deficiency, partial ADA deficiency].
Sakiyama Y
Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):454-7. PubMed ID: 9590099
[No Abstract] [Full Text] [Related]
9. Progress in genetic therapy for severe combined immunodeficiency associated with adenosine deaminase deficiency.
Williams DA
Mol Ther; 2009 Apr; 17(4):577-8. PubMed ID: 19337228
[No Abstract] [Full Text] [Related]
10. Gene therapy of primary immunodeficiencies.
Fischer A; De Saint Basile G; Disanto JP; Hacein-Bey S; Sharara L; Cavazzana-Calvo M
Adv Nephrol Necker Hosp; 1997; 26():107-20. PubMed ID: 8922128
[No Abstract] [Full Text] [Related]
11. Progress in primary immunodeficiency.
Matsumoto S; Sakiyama Y; Ariga T; Gallagher R; Taguchi Y
Immunol Today; 1992 Jan; 13(1):4-5. PubMed ID: 1739431
[TBL] [Abstract][Full Text] [Related]
12. Management options: SCIDS with adenosine deaminase deficiency.
Hilman BC; Sorensen RU
Ann Allergy; 1994 May; 72(5):395-403; quiz 403-4, 407. PubMed ID: 8179225
[TBL] [Abstract][Full Text] [Related]
13. Bilateral sensorineural deafness in adenosine deaminase-deficient severe combined immunodeficiency.
Albuquerque W; Gaspar HB
J Pediatr; 2004 Feb; 144(2):278-80. PubMed ID: 14760277
[TBL] [Abstract][Full Text] [Related]
14. New insights into adenosine-receptor-mediated immunosuppression and the role of adenosine in causing the immunodeficiency associated with adenosine deaminase deficiency.
Hershfield MS
Eur J Immunol; 2005 Jan; 35(1):25-30. PubMed ID: 15580654
[TBL] [Abstract][Full Text] [Related]
15. Natural gene therapy and the Darwinian legacy.
Youssoufian H
Nat Genet; 1996 Jul; 13(3):255-6. PubMed ID: 8673116
[No Abstract] [Full Text] [Related]
16. Amendment to Clinical Research Project. Project 90-C-195. April 1, 1993. Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with autologous lymphocytes transduced with a human ADA gene.
Dunbar C; Chang L; Mullen C; Ramsey WJ; Carter C; Kohn D; Parkman R; Lenarsky C; Weinberg K; Wara D; Culver KW; Anderson WF; Leitman S; Fleisher T; Klein H; Shearer G; Clerici M; McGarrity G; Bastian J; Hershfield MS
Hum Gene Ther; 1999 Feb; 10(3):477-88. PubMed ID: 10048399
[No Abstract] [Full Text] [Related]
17. [Adenosine deaminase].
Yoshino M; Murakami K
Nihon Rinsho; 2003 Jan; 61 Suppl 1():91-4. PubMed ID: 12629697
[No Abstract] [Full Text] [Related]
18. [Severe combined immunodeficiencies: a case of adenosine-deaminase deficit].
Macellaro P; Savarino A; Cucchi G; Lazzati A; Zuccotti GV
Pediatr Med Chir; 2004; 26(3):191-5. PubMed ID: 16366403
[TBL] [Abstract][Full Text] [Related]
19. Effects of metabolic disorders on the brain: can these effects be reversed with bone marrow transplantation?
Hershey AD
J Pediatr; 2001 Jul; 139(1):9-11. PubMed ID: 11445784
[No Abstract] [Full Text] [Related]
20. The importance of adenosine deaminase for lymphocyte development and function.
Aldrich MB; Blackburn MR; Kellems RE
Biochem Biophys Res Commun; 2000 Jun; 272(2):311-5. PubMed ID: 10833410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
